Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-06-19

FDA Approved: SUPPRELIN LA — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for SUPPRELIN LA (histrelin acetate) from Endo USA, Inc., expanding its regulatory approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SUPPRELIN LA (HISTRELIN ACETATE)

Snippet

SUPPL AP for SUPPRELIN LA (HISTRELIN ACETATE)